PRENW Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-11.040.0% YoY
Profit margin-63.1%
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
-31.8%
Operating margin
-33.3%
Revenue growth YoY
248.6%
Dividend yield
Beta
0.27

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Prenetics Holding Company Limited

Prenetics Holding Company Limited is a pioneering global healthcare technology firm dedicated to enhancing health outcomes through innovative genetic testing and digital health solutions. By offering a comprehensive suite of genetic screening and diagnostics, the company utilizes advanced technologies and data analytics to drive personalized medicine and deliver actionable health insights. As the market for precision health solutions continues to grow, Prenetics is strategically expanding its product offerings to seize emerging opportunities in a rapidly evolving, data-driven healthcare…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
UNIT 703-706, K11 ATELIER KING?S ROAD, QUARRY BAY
Fiscal year end
December
Latest quarter
Mar 31, 2026
Shares outstanding$0
52W high$0.07
52W low$0.01

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer